(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CELLCIPHR

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CELLCIPHR

ST13

US500000077121298

Classe

1, 42

Pedido

77121298

Registro

3343078

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

44

Atualização mais recente

29/11/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 42

Data de depósito

02/03/2007

Data de registro

27/11/2007

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/05/2017

Última transação

29/11/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Primeiro uso

02/03/2007

Primeiro uso no comércio

02/03/2007

Código do desenho

4

Tipo de titular

16

Localização do titular

Beijing, US

Examinador

MAHONEY, PAULA M

Unidade examinadora

M80

Localização atual

TMO LAW OFFICE 117

Titulares e representantes

Titulares

CYPROTEX US, LLC
APREDICA LLC
Cellumen, Inc.

Representantes

William E OBrien, Esq. OBrien Global Law

Classificação técnica

Classes Nice

Classe 1Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals namelypolypeptides for in vitro research use; Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Biological Tissuea set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Chemical preparations for scientific purposes; Chemical test kits for cell assays for laboratory or research use; Cytological fixatives; Diagnostic preparations for scientific or research use; Enzymes for scientific and research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use

Classe 42

Chemicalbiochemicalbiological and bacteriological research and analysis; Chemistry consultation; Consultancy pertaining to pharmacology; Design for others in the field of cellular profiling and biomedical assays; Development of new technology for others in the field of biomedical research; Diagnostic services in the field of biomedicine; Information on the subject of scientific research in the field of biochemistry and biotechnology; Laboratory research in the field of drug discovery and drug development; Measurement evaluations in the fields of cell biology and biomedicine; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of drug discovery and drug development; Medical and scientific research services in the field of cancer treatment and diagnosis; Medical research; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Research and development and consultation related thereto in the field of drug discovery and drug development; Research in the field of environmental protection; Scientific investigations for medical purposes; Scientific research ; Technology consultation and research in the field of biomedicine

Publicações

Histórico de despachos e eventos da marca no USPTO.

44 publicações encontradas

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

29/11/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

29/11/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

29/11/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

29/11/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/10/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/10/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/10/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/10/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/10/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/10/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

30/09/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

30/09/2020

ES7R

TEAS SECTION 7 REQUEST RECEIVED

17/07/2020

ES7R

TEAS SECTION 7 REQUEST RECEIVED

29/06/2020

ES7S

TEAS SECTION 7 SURRENDER RECEIVED

26/05/2020

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

24/05/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

24/05/2017

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

24/05/2017

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

24/05/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

24/05/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

29/03/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

29/03/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

27/11/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

23/07/2014

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/04/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/04/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/04/2013

E815

TEAS SECTION 8 & 15 RECEIVED

14/03/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

14/03/2013

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/11/2012

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

14/09/2011

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

31/08/2011

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

25/02/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

27/11/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/11/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/11/2007

PUBO

PUBLISHED FOR OPPOSITION

11/09/2007

NPUB

NOTICE OF PUBLICATION

22/08/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/08/2007

ALIE

ASSIGNED TO LIE

08/08/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/06/2007

DOCK

ASSIGNED TO EXAMINER

14/06/2007

MPMK

NOTICE OF PSEUDO MARK MAILED

08/03/2007

NWAP

NEW APPLICATION ENTERED

07/03/2007

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CELLCIPHR ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.